Bio Techne Stock Options

TECH Stock  USD 64.92  0.57  0.87%   
Bio Techne's latest option contracts expiring on April 17th 2025 are carrying combined implied volatility of 0.59 with a put-to-call open interest ratio of 1.14 over 28 outstanding agreements suggesting investors are buying more puts than calls on contracts expiring on April 17th 2025.

Open Interest Against April 17th 2025 Option Contracts

8070Calls Open InterestPuts Open Interest100%
The chart above shows Bio Techne's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Bio Techne's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Bio Techne's option, there is no secondary market available for investors to trade.

In The Money vs. Out of Money Option Contracts on Bio Techne

Analyzing Bio Techne's in-the-money options over time can help investors to take a profitable long position in Bio Techne regardless of its overall volatility. This is especially true when Bio Techne's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Bio Techne's options could be used as guardians of the underlying stock as they move almost dollar for dollar with Bio Techne's stock while costing only a fraction of its price.
In The Money Calls:Out Of Money Calls:In The Money Puts:Out Of Money Puts:

Bio Techne Corp In The Money Call Balance

When Bio Techne's strike price is surpassing the current stock price, the option contract against Bio Techne Corp stock is said to be in the money. When it comes to buying Bio Techne's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Bio Techne Corp are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

Bio Current Options Market Mood

Bio Techne's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Bio Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Most options investors, including buyers and sellers of Bio Techne's calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Bio Techne's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.

Rule 16 of the current Bio contract

Base on the Rule 16, the options market is currently suggesting that Bio Techne Corp will have an average daily up or down price movement of about 0.0369% per day over the life of the 2025-04-17 option contract. With Bio Techne trading at USD 64.92, that is roughly USD 0.0239. If you think that the market is fully incorporating Bio Techne's daily price movement you should consider buying Bio Techne Corp options at the current volatility level of 0.59%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
  
Purchasing Bio Techne options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Bio calls. Remember, the seller must deliver Bio Techne Corp stock to the call owner when a call is exercised.

Bio Techne Option Chain

When Bio Techne's strike price is surpassing the current stock price, the option contract against Bio Techne Corp stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Bio Techne's option chain is a display of a range of information that helps investors for ways to trade options on Bio. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Bio. It also shows strike prices and maturity days for a Bio Techne against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntStrike PriceCurrent SpreadLast Price
Call
TECH250417C00040000140.023.3 - 27.535.2In
Call
TECH250417C00060000160.05.1 - 8.119.0In
Call
TECH250417C00065000665.03.4 - 4.26.65Out
Call
TECH250417C00070000270.01.4 - 2.151.98Out
Call
TECH250417C000750002775.00.55 - 1.20.81Out
Call
TECH250417C000800004980.00.05 - 2.250.2Out
Call
TECH250417C000850001985.00.0 - 2.252.92Out
Call
TECH250417C000900001090.00.0 - 1.43.0Out
Call
TECH250417C000950001695.00.0 - 2.151.6Out
Call
TECH250417C001000008100.00.0 - 2.152.61Out
Call
TECH250417C001050000105.00.0 - 2.152.15Out
Call
TECH250417C001100003110.00.0 - 1.350.19Out
Call
TECH250417C001150002115.00.0 - 0.60.39Out
 Put
TECH250417P00040000240.00.0 - 1.60.05Out
 Put
TECH250417P00050000150.00.15 - 1.951.45Out
 Put
TECH250417P000550001055.00.25 - 1.850.3Out
 Put
TECH250417P00060000960.00.05 - 2.11.1Out
 Put
TECH250417P000650002365.03.1 - 3.82.7Out
 Put
TECH250417P0007000011770.04.5 - 7.05.3In
 Put
TECH250417P00075000175.09.6 - 11.37.69In
 Put
TECH250417P00080000180.013.4 - 16.38.6In
 Put
TECH250417P00085000085.018.1 - 22.218.1In
 Put
TECH250417P00090000090.023.1 - 27.323.1In
 Put
TECH250417P00095000095.028.3 - 32.319.1In
 Put
TECH250417P001000000100.033.1 - 37.333.1In
 Put
TECH250417P001050000105.038.1 - 42.338.1In
 Put
TECH250417P001100000110.043.3 - 47.343.3In
 Put
TECH250417P001150000115.048.0 - 52.348.0In

Bio Techne Selling And Marketing Expenses Over Time

   Selling And Marketing Expenses   
       Timeline  

Bio Total Stockholder Equity

Total Stockholder Equity

2.5 Billion

As of now, Bio Techne's Total Stockholder Equity is increasing as compared to previous years.

Bio Techne Corporate Management

Lynne HohlfeldSenior DivisionProfile
Luca CicchettiManaging DirectorProfile
Brenda JDGen VPProfile
Martin WirtzSenior DevelopmentProfile
Cheryl BethuneSenior OfficerProfile
When determining whether Bio Techne Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bio Techne's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Techne Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Techne Corp Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Bio Techne Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bio Techne. If investors know Bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bio Techne listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.294
Dividend Share
0.32
Earnings Share
0.98
Revenue Per Share
7.568
Quarterly Revenue Growth
0.09
The market value of Bio Techne Corp is measured differently than its book value, which is the value of Bio that is recorded on the company's balance sheet. Investors also form their own opinion of Bio Techne's value that differs from its market value or its book value, called intrinsic value, which is Bio Techne's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bio Techne's market value can be influenced by many factors that don't directly affect Bio Techne's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bio Techne's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Techne is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio Techne's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
News Freq…Investor S…